NCT07169851: A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 204 planned
- Started
- 28 Nov 2025
- Primary completion
- Dec 2026
- Arms
- LY3537021 + Antiemetic Therapies
- Results
- None posted
- 12 Sep 2025: Trial registered
- 28 Nov 2025: Trial started